オンコリスバイオファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/07/16 | 1,302 | 1,319 | 1,271 | 1,301 | -1 | -0.1% | 235,300 |
| 2021/07/15 | 1,350 | 1,350 | 1,286 | 1,302 | -52 | -3.8% | 395,800 |
| 2021/07/14 | 1,358 | 1,362 | 1,338 | 1,354 | -4 | -0.3% | 159,400 |
| 2021/07/13 | 1,384 | 1,394 | 1,335 | 1,358 | -22 | -1.6% | 299,300 |
| 2021/07/12 | 1,372 | 1,402 | 1,363 | 1,380 | -8 | -0.6% | 209,800 |
| 2021/07/09 | 1,352 | 1,412 | 1,352 | 1,388 | +14 | +1% | 384,700 |
| 2021/07/08 | 1,405 | 1,406 | 1,362 | 1,374 | -50 | -3.5% | 406,700 |
| 2021/07/07 | 1,444 | 1,460 | 1,410 | 1,424 | -33 | -2.3% | 328,000 |
| 2021/07/06 | 1,441 | 1,480 | 1,411 | 1,457 | +6 | +0.4% | 471,500 |
| 2021/07/05 | 1,475 | 1,514 | 1,441 | 1,451 | +11 | +0.8% | 646,700 |
| 2021/07/02 | 1,578 | 1,585 | 1,426 | 1,440 | -113 | -7.3% | 1,439,400 |
| 2021/07/01 | 1,553 | 1,602 | 1,534 | 1,553 | -2 | -0.1% | 655,400 |
| 2021/06/30 | 1,652 | 1,655 | 1,533 | 1,555 | -71 | -4.4% | 1,136,500 |
| 2021/06/29 | 1,738 | 1,743 | 1,608 | 1,626 | -76 | -4.5% | 1,070,600 |
| 2021/06/28 | 1,837 | 1,847 | 1,680 | 1,702 | -145 | -7.9% | 1,494,000 |
| 2021/06/25 | 1,874 | 1,938 | 1,813 | 1,847 | -7 | -0.4% | 1,128,100 |
| 2021/06/24 | 1,866 | 1,918 | 1,811 | 1,854 | -26 | -1.4% | 1,141,200 |
| 2021/06/23 | 1,762 | 1,893 | 1,762 | 1,880 | +127 | +7.2% | 1,191,500 |
| 2021/06/22 | 1,736 | 1,766 | 1,673 | 1,753 | +39 | +2.3% | 780,500 |
| 2021/06/21 | 1,692 | 1,748 | 1,681 | 1,714 | -16 | -0.9% | 537,700 |
| 2021/06/18 | 1,740 | 1,773 | 1,692 | 1,730 | ±0 | ±0% | 760,200 |
| 2021/06/17 | 1,698 | 1,750 | 1,661 | 1,730 | +23 | +1.3% | 1,120,200 |
| 2021/06/16 | 1,583 | 1,722 | 1,562 | 1,707 | +131 | +8.3% | 2,082,700 |
| 2021/06/15 | 1,510 | 1,591 | 1,503 | 1,576 | +53 | +3.5% | 636,400 |
| 2021/06/14 | 1,631 | 1,649 | 1,513 | 1,523 | -14 | -0.9% | 1,718,400 |
| 2021/06/11 | 1,517 | 1,581 | 1,505 | 1,537 | +42 | +2.8% | 685,300 |
| 2021/06/10 | 1,499 | 1,534 | 1,474 | 1,495 | +4 | +0.3% | 433,400 |
| 2021/06/09 | 1,450 | 1,522 | 1,438 | 1,491 | +23 | +1.6% | 554,700 |
| 2021/06/08 | 1,440 | 1,484 | 1,403 | 1,468 | +81 | +5.8% | 784,900 |
| 2021/06/07 | 1,383 | 1,394 | 1,345 | 1,387 | +17 | +1.2% | 215,500 |
| 2021/06/04 | 1,415 | 1,422 | 1,359 | 1,370 | -57 | -4% | 445,400 |
| 2021/06/03 | 1,424 | 1,448 | 1,407 | 1,427 | -6 | -0.4% | 290,100 |
| 2021/06/02 | 1,440 | 1,475 | 1,431 | 1,433 | +4 | +0.3% | 441,000 |
| 2021/06/01 | 1,434 | 1,441 | 1,403 | 1,429 | ±0 | ±0% | 246,100 |
| 2021/05/31 | 1,391 | 1,456 | 1,390 | 1,429 | +51 | +3.7% | 607,700 |
| 2021/05/28 | 1,370 | 1,388 | 1,347 | 1,378 | +20 | +1.5% | 237,400 |
| 2021/05/27 | 1,360 | 1,371 | 1,316 | 1,358 | -2 | -0.1% | 273,700 |
| 2021/05/26 | 1,352 | 1,374 | 1,342 | 1,360 | +8 | +0.6% | 200,600 |
| 2021/05/25 | 1,339 | 1,375 | 1,327 | 1,352 | +42 | +3.2% | 301,900 |
| 2021/05/24 | 1,384 | 1,384 | 1,304 | 1,310 | -58 | -4.2% | 437,700 |
| 2021/05/21 | 1,356 | 1,390 | 1,347 | 1,368 | +33 | +2.5% | 358,800 |
| 2021/05/20 | 1,325 | 1,360 | 1,293 | 1,335 | +3 | +0.2% | 396,800 |
| 2021/05/19 | 1,310 | 1,386 | 1,306 | 1,332 | +12 | +0.9% | 681,900 |
| 2021/05/18 | 1,279 | 1,326 | 1,260 | 1,320 | +44 | +3.4% | 502,600 |
| 2021/05/17 | 1,295 | 1,316 | 1,232 | 1,276 | -2 | -0.2% | 511,400 |
| 2021/05/14 | 1,228 | 1,285 | 1,211 | 1,278 | +38 | +3.1% | 450,300 |
| 2021/05/13 | 1,220 | 1,274 | 1,175 | 1,240 | +39 | +3.2% | 668,900 |
| 2021/05/12 | 1,243 | 1,257 | 1,183 | 1,201 | -64 | -5.1% | 475,500 |
| 2021/05/11 | 1,245 | 1,297 | 1,202 | 1,265 | +16 | +1.3% | 1,031,500 |
| 2021/05/10 | 1,150 | 1,255 | 1,150 | 1,249 | +90 | +7.8% | 713,800 |
951～
1000
件表示中 / 2808件
類似銘柄と比較する
現在ご覧いただいている「オンコリス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| オンコリス | 66,400円 | +3771.0% | - | 0.00% | - | 6.01倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
| ステムリム | 30,800円 | - | - | 0.00% | - | 2.84倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| ＣＡＮＢＡＳ | 93,200円 | - | - | 0.00% | - | 5.96倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| ラクオリア | 62,800円 | +25.1% | - | 0.00% | - | 2.77倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
| Ｃｈｏｒｄｉａ | 22,100円 | - | - | 0.00% | - | 4.70倍 |
|
ＲＮＡ制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
市場注目の銘柄
チャート関連のコラム
